1. Alayash AI 2004 Oxygen therapeutics: can we tame haemoglobin? Nat. Rev. Drug Discov. 3 152–159
2. Antonini E and Brunori M 1971 Hemoglobin and myoglobin in their reaction with ligands (Amsterdam: North-Holland)
3. Arafat WO, Casado E, Wang M, Alvarez RD, Siegal GP, Glorioso JC, Curiel DT and Gomez-Navarro J 2000 Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells. Clin. Cancer Res. 6 4442–4448
4. Blomberg LM, Blomberg MRA and Siegbahn PEM 2004 A theoretical study of myoglobin working as a nitric oxide scavenger. J. Biol. Inorg. Chem. 9 923–935
5. Cooper CE, Silaghi-Dumitrescu R, Rukengwa M, Alayash AI and Buehler PW 2008 Peroxidase activity of hemoglobin towards ascorbate and urate: a synergistic protective strategy against toxicity of hemoglobin-based oxygen carriers (HBOC). Biochim. Biophys. Acta 1784 1415–1420